Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients-Reference-Cited by-同舟云学术

Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients

Published:2013-02 Issue:2 Volume:23 Page:139-148
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Servais L.,Deconinck N.,Moraux A.,Benali M.,Canal A.,Van Parys F.,Vereecke W.,Wittevrongel S.,Mayer M.,Desguerre I.,Maincent K.,Themar-Noel C.,Quijano-Roy S.,Serari N.,Voit T.,Hogrel J.-Y.

Funder

ADNA (Advanced Diagnostics for New Therapeutic Approaches)

French public agency, OSEO

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD/ENMC Workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD Workshop on outcome measures in experimental trials for DMD, 30th June–1st July 2007, Naarden, The Netherlands; Conjoint Institute of Myology TREAT-NMD Meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France

2. Choosing the right clinical outcome measure: from the patient to the statistician and back;Mercuri;Neuromuscul Disord,2010

3. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study;Cirak;Lancet,2011

4. Systemic administration of PRO051 in Duchenne’s muscular dystrophy;Goemans;N Engl J Med,2011

5. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study;Mazzone;Neurology,2011

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between Hand Strength and Function in Duchenne Muscular Dystrophy and Spinal Muscular Atrophy: Implications for Clinical Trials;Journal of Neuromuscular Diseases;2024-07-02

2. Long-term monitoring of stimulated lower leg skeletal muscle forces compared with voluntary contractions in myopathy patients – A five-year follow-up report on 5 adults;Journal of Bodywork and Movement Therapies;2024-04

3. A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice;PLOS ONE;2024-01-25

4. Pathogenic DPAGT1 variants in limb‐girdle congenital myasthenic syndrome (LG‐CMS) associated with tubular aggregates and ORAI1 hypoglycosylation;Neuropathology and Applied Neurobiology;2024-01-21

5. Design requirements of upper extremity supports for daily use in Duchenne muscular dystrophy with severe muscle weakness;Journal of Rehabilitation and Assistive Technologies Engineering;2024-01